Proof-of-principle studies from our laboratory show that it is possible to restrict breast cancer cell growth by targeting BAG-1 protein-protein interactions using synthetic peptides and small molecule compounds, like Thioflavin S (Thio-S) and its biologically potent constituent Thio-2 [27–29]. The gene discussed is BAG1; the disease is breast cancer.